Profound Medical (PROF) Cash from Investing Activities (2019 - 2021)
Profound Medical has reported Cash from Investing Activities over the past 3 years, most recently at -$127000.0 for Q4 2021.
- For Q4 2021, Cash from Investing Activities rose 63.71% year-over-year to -$127000.0; the TTM value through Dec 2021 reached -$593000.0, changed N/A, while the annual FY2025 figure was -$242000.0, N/A changed from the prior year.
- Cash from Investing Activities for Q4 2021 was -$127000.0 at Profound Medical, down from -$121000.0 in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $189000.0 in Q4 2019 and troughed at -$350000.0 in Q4 2020.
- A 3-year average of -$125666.7 and a median of -$145500.0 in 2021 define the central range for Cash from Investing Activities.
- Biggest five-year swings in Cash from Investing Activities: crashed 285.19% in 2020 and later skyrocketed 63.71% in 2021.
- Year by year, Cash from Investing Activities stood at $189000.0 in 2019, then crashed by 285.19% to -$350000.0 in 2020, then skyrocketed by 63.71% to -$127000.0 in 2021.
- Business Quant data shows Cash from Investing Activities for PROF at -$127000.0 in Q4 2021, -$121000.0 in Q3 2021, and -$164000.0 in Q2 2021.